Pharmacology I: Effects on Sleep of Commonly Used ICU Medications

Critical Care Clinics

Volumn 24, Issue 3, 2008, Pages 477-491

  Weinhouse, Gerald L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMIODARONE; ANTIDEPRESSANT AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CAPTOPRIL; CARBAMAZEPINE; CIMETIDINE; CLONIDINE; DEXMEDETOMIDINE; DIURETIC AGENT; DOPAMINE; GABAPENTIN; HALOPERIDOL; HYDRALAZINE; METHYLDOPA; OLANZAPINE; OPIATE; PHENYTOIN; PRAZOSIN; PREDNISONE; PROPOFOL; RISPERIDONE; THEOPHYLLINE; TRAZODONE; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE;

ANTIHYPERTENSIVE THERAPY; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DRUG EFFECT; DRUG HALF LIFE; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; HYPOTENSION; INSOMNIA; INTENSIVE CARE UNIT; NIGHTMARE; PRIORITY JOURNAL; REVIEW; SINGLE DRUG DOSE; SLEEP DISORDER; TREATMENT DURATION;

HUMANS; INTENSIVE CARE UNITS; RESTLESS LEGS SYNDROME; SLEEP APNEA SYNDROMES; SLEEP STAGES;

EID: 44449089405     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2008.02.008     Document Type: Review

References (111)

1. Aurell J., and Elmqvist D. Sleep in the surgical intensive care unit: continuous polygraphic recording of sleep in nine patients receiving postoperative care. BMJ 290 (1985) 1029-1032
2. Cooper A.B., Thornley K.S., Young G.B., et al. Sleep in critically ill patients requiring mechanical ventilation. Chest 117 (2000) 809-818
3. Richards K.C., and Bairnsfather L. A description of night sleep patterns in the critical care unit. Heart Lung 17 (1988) 35-42
4. Broughton R., and Baron R. Sleep patterns in the intensive care unit and on the ward after acute myocardial infarction. Electroencephalogr Clin Neurophysiol 45 (1978) 348-360
5. Orr W.C., and Stahl M.L. Sleep disturbances after open heart surgery. Am J Cardiol 39 (1977) 196-201
6. Freedman N.S., Gazendam J., Levan L., et al. Abnormal sleep/wake cycles and the effect of environmental noise on sleep disruption in the intensive care unit. Am J Respir Crit Care Med 163 (2001) 451-457
7. Gabor J., Cooper A., Crombach S., et al. Contribution of the intensive care unit environment to sleep disruption in mechanically ventilated patients and healthy subjects. Am J Respir Crit Care Med 167 (2003) 708-715
8. Novak M., and Shapiro C.M. Drug-induced sleep disturbances: focus on nonpsychotropic medications. Drug Saf 16 2 (1997) 133-149
9. Bourne R.S., and Mills G.H. Sleep disruption in critically ill patients-pharmacological considerations. Anaesthesia 59 (2004) 374-384
10. Wiegand L., Mende C.N., Zaidel G., et al. Salmeterol vs theophylline: sleep and efficacy outcomes in patients with nocturnal asthma. Chest 115 6 (1999) 1525-1532
11. Bjornstrom K., and Eintrei C. The difference between sleep and anaesthesia is in the intracellular signal: propofol and GABA use different subtypes of the GABA(A) receptor beta subunit and vary in their interaction with actin. Acta Anaesthesiol Scand 47 2 (2003) 157-164
12. Hales T.G., and Lambert J.J. The actions of propofol on inhibitory amino acid receptors of bovine adrenomedullary chromaffin cells and rodent central neurons. Br J Pharmacol 104 (1991) 619-628
13. Saper C.B., Scammell T.E., and Lu J. Hypothalamic regulation of sleep and circadian rhythms. Nature 437 (2005) 1257-1263
14. A receptors in an endogenous sleep pathway. Nat Neurosci 5 10 (2002) 979-984
15. Tung A., and Mendelson W.B. Anesthesia and sleep. Sleep Med Rev 8 (2004) 213-225
16. Borbely A.A., Mattmann P., Loepfe M., et al. Effect of benzodiazepine hypnotics on all-night sleep EEG spectra. Human Neurobiology 4 (1985) 189-194
17. Achermann P., and Borbely A.A. Dynamics of EEG slow wave activity during physiological sleep and after administration of benzodiazepine hypnotics. Hum Neurobiol 6 (1987) 203-210
18. Herregods L., Rolly G., Mortier E., et al. EEG and SEMG monitoring during induction and maintenance of anaesthesia with propofol. Int J Clin Monit Comput 6 (1989) 67-73
19. Feshchenko V.A., Veselis R.A., and Reinsel R.A. Comparison of the EEG effects of midazolam, thiopental, and propofol: the role of underlying oscillatory systems. Neuropsychobiology 35 (1997) 211-220
20. Hazeaux C., Tisserant D., Vespignani H., et al. Electro-encephalographic changes produced by propofol. Ann Fr Anesth Reanim 6 (1987) 261-266
21. Harrison A.M., Lugo R.A., Schunk J.E., et al. Treatment of convulsive status epilepticus with propofol: case report. Pediatric Emergency Care 13 (1997) 420-422
22. Claassen J., Hirsch L.J., Emerson R.G., et al. Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus. Neurology 57 6 (2001) 1036-1042
23. 2O PET study. Am J Psychiatry 161 4 (2004) 748-751
24. Alkire M.T., Haier R.J., Barker S.J., et al. Cerebral metabolism during propofol anesthesia in humans studied with positron emission tomography. Anesthesiology 82 2 (1995) 393-403
25. Tung A., Lynch J.P., and Mendelson W.B. Prolonged sedation with propofol in the rat does not result in sleep deprivation. Anesth Analg 92 5 (2001) 1232-1236
26. Tung A., Bergmann B.M., Herrera S., et al. Recovery from sleep deprivation occurs during propofol anesthesia. Anesthesiology 100 6 (2004) 1419-1426
27. 2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effect. Anesthesiology 98 2 (2003) 428-436
28. Keifer J.C., Baghdoyan H.A., and Lydic R. Sleep disruption and increased apneas after pontine microinjection of morphine. Anesthesiology 77 (1992) 973-982
29. Shaw I.R., Gilles L., Mayer P., et al. Acute intravenous administration of morphine perturbs sleep architecture in healthy pain-free young adults: a preliminary study. Sleep 28 6 (2005) 677-682
30. Dimsdale J.E., Norman D., DeJardin D., et al. The effects of opioids on sleep architecture. J Clin Sleep Med 3 1 (2007) 33-36
31. Cronin A., Keifer J.C., Baghdoyan H.A., et al. Opioid inhibition of rapid eye movement sleep by a specific mu receptor agonist. Br J Anaesth 74 (1995) 188-192
32. Caldwell J.R., Rapoport R.J., Davis J.C., et al. Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: results from a randomized, placebo-controlled double-blind trial and an open-label extension trial. J Pain Symptom Manage 23 4 (2002) 278-291
33. Murphy P.J., Badia P., Myers B.L., et al. Nonsteroidal anti-inflammatory drugs affect normal sleep patterns in humans. Physiol Behav 55 (1994) 1063-1066
34. Murphy P.J., Myers B.L., and Badia P. Nonsteroid anti-inflammatory drugs alter body temperature and suppress melatonin in humans. Physiol Behav 59 (1996) 133-139
35. Jakobsen C.J., Bille S., Ahlburg P., et al. Perioperative metoprolol reduces the frequency of atrial fibrillation after thoracotomy for lung resection. J Cardiothorac Vasc Anesth 11 6 (1997) 746-751
36. Urban M.K., Markowitz S.M., Gordon M.A., et al. Postoperative prophylactic administration of [beta]-adrenergic blockers in patients at risk for myocardial ischemia. Anesth Analg 90 6 (2000) 1257-1261
37. Arbabi S., Ahrns K.S., Wahl W.L., et al. Beta-blocker use is associated with improved outcomes in adult burn patients. J Trauma 56 (2004) 265-271
38. Egan B.M., Basile J., Chilton R.J., et al. Cardioprotection: the role of beta-blocker therapy. J Clin Hypertens 7 7 (2005) 409-416
39. McAinsh J., and Cruickshank J.M. Beta-blockers and central nervous system side effects. Pharmacol Ther 46 (1990) 163-197
40. Reiffel J.A. Intravenous amiodarone in the management of atrial fibrillation. J Cardiovasc Pharmacol Ther 4 (1999) 199-204
41. Swales J.D. ACE inhibitors and the quality of life. J Cardiovasc Pharmacol 9 Suppl (1987) S22-S25
42. Materson B.J., and Preston R.A. Angiotensin-converting enzyme inhibitors in hypertension-a dozen years of experience. Arch Intern Med 154 (1994) 513-523
43. Breckenridge A. Angiotensin converting enzyme inhibitors and quality of life. Am J Hypertens 4 (1991) 79S-82S
44. Fletcher A.E., Bulpitt C.J., Hawkins C.M., et al. Quality of life on antihypertensive therapy: a randomized double-blind controlled trial of captopril and atenolol. J Hypertens 8 (1990) 463-466
45. Kanno O., and Clarenbach P. Effects of clonidine and yohimbine on sleep in man: polygraphic study and EEG analysis by normalized slope descriptors. Electroencephalogr Clin Neurophysiol 60 (1985) 478-484
46. Gentili A., Godschalk M.F., Gheorghiu D., et al. Effect of clonidine and yohimbine on sleep in healthy men: a double-blind, randomized, controlled trial. Eur J Clin Pharmacol 50 6 (1996) 463-465
47. Oldendorf W.H. Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection. Am J Physiol 221 (1971) 1629-1639
48. Myburgh J.A., Upton R.N., Grant C., et al. The cerebrovascular effects of adrenaline, noradrenaline and dopamine infusion under propofol and isoflurane anaesthesia in sheep. Anaesth Intensive Care 30 (2002) 725-733
49. Andrzejowski J., Sleigh J.W., Johnson I.A., et al. The effect of intravenous epinephrine on the bispectral index and sedation. Anaesthesia 55 (2000) 761-763
50. Fleetham J., West P., and Mezon B. Sleep, arousals, and oxygen desaturation in chronic obstructive pulmonary disease. Am Rev Respir Dis 126 (1982) 429-433
51. Calverley P.M.A., Brezinova V., Douglas N.J., et al. The effect of oxygenation on sleep quality in chronic bronchitis and emphysema. Am Rev Respir Dis 126 (1982) 206-210
52. Man G.C.W., Chapman K.R., Ali S., et al. Sleep quality and nocturnal respiratory function with once-daily theophylline (Uniphyl) and inhaled salbutamol in patients with COPD. Chest 110 3 (1996) 648-653
53. Bailey W.C., Richards J.M., Manzella B.A., et al. Characteristics and correlates of asthma in a university clinic population. Chest 98 (1990) 821-828
54. Janson C., Gislason T., Boman G., et al. Sleep disturbances in patients with asthma. Respir Med 84 (1990) 37-42
55. Berry R.B., Desa M.M., Branum J.P., et al. Effect of theophylline on sleep and sleep disordered breathing in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 143 (1991) 245-250
56. Fitzpatrick M.F., Engleman H.M., Boellert F., et al. Effect of therapeutic theophylline levels on the sleep quality and daytime cognitive performance of normal subjects. Am Rev Respir Dis 145 (1992) 1355-1358
57. Martin R.J., and Pak J. Overnight theophylline concentrations and effects on sleep and lung function in chronic obstructive pulmonary disease. Am Rev Respir Dis 145 (1992) 540-544
58. Zwillich C.W., Neagley S.R., Cicutto L., et al. Nocturnal asthma therapy: inhaled bitolterol versus sustained-release theophylline. Am Rev Respir Dis 139 (1989) 470-474
59. Born J., Zwick A., Roth G., et al. Differential effects of hydrocortisone, fluocortolone, and aldosterone on nocturnal sleep in humans. Acta Endocrinol (Copenh) 116 (1987) 129-137
60. Wolkowitz O.M., Rubinow D., Doran A.R., et al. Prednisone effects on neurochemistry and behavior: preliminary findings. Arch Gen Psychiatry 47 (1990) 963-968
61. Berlin R.G. Effects of H2-receptor antagonists on the central nervous system. Drug Dev Res 17 (1989) 97-108
62. Gimenez S., Clos S., Romero S., et al. Effects of olanzapine, risperidone and haloperidol on sleep after a single oral morning dose in healthy volunteers. Psychopharmacology 190 (2007) 507-516
63. Yamashita H., Morinobu S., Yamawaki S., et al. Effect of risperidone on sleep in schizophrenia: a comparison with haloperidol. Psychiatry Res 109 (2002) 137-142
64. Akerstedt T., Hume K., Minors D., et al. Good sleep-its timing and physiological sleep characteristics. J Sleep Res 6 (1997) 221-229
65. Gursky J.T., and Krahn L.E. The effects of antidepressants on sleep: a review. Harv Rev Psychiatry 8 (2000) 298-306
66. Armitage R. Effects of antidepressant treatment on sleep EEG in depression. J Psychopharmacol 10 Suppl 1 (1996) 22-25
67. Dunleavy D.L., Brezinova V., Oswald I., et al. Changes during weeks in effects of tricyclic drugs on the human sleeping brain. Br J Psychiatry 120 (1972) 663-672
68. Nicholson A.N., Pascoe P.A., and Turner C. Modulation of sleep by trimipramine in man. Eur J Clin Pharmacol 37 (1989) 145-150
69. Nicholson A.N., and Pascoe P.A. Studies on the modulation of the sleep-wakefulness continuum in man by fluoxetine, a 5-HT uptake inhibitor. Neuropharmacology 27 (1988) 597-602
70. Von Bardeleben U.V., Steiger A., Gerken A., et al. Effects of fluoxetine upon pharmacoendocrine and sleep-EEG parameters in normal controls. Int Clin Psychopharmacol 4 Suppl 1 (1989) 1-5
71. Hendrickse W.A., Roffwarg H.P., Grannemann B.D., et al. The effects of fluoxetine on the polysomnogram of depressed outpatients: a pilot study. Neuropsychopharmacology 10 (1994) 85-91
72. Kerkhofs M., Rielaert C., DeMaertelaer V., et al. Fluoxetine in major depression: efficacy, safety and effects on sleep polygraphic variables. Int Clin Psychopharmacol 5 (1990) 253-260
73. Staner L., Kerkhofs M., Detroux D., et al. Acute, subchronic and withdrawal sleep EEG changes during treatment with paroxetine and amitriptyline: a double-blind randomized trial in major depression. Sleep 18 (1995) 470-477
74. Van Bemmel A.L., Havermans R.G., and Van Diest R. Effects of trazodone on EEG sleep and clinical state in major depression. Psychopharmacology (Berl) 107 (1992) 569-574
75. Scharf M.B., and Sachais B.A. Sleep laboratory evaluation of the effects and efficacy of trazodone in depressed insomniac patients. J Clin Psychiatry 51 Suppl (1990) 13-17
76. Mouret J., Lemoine P., Minuit M.P., et al. Effects of trazodone on the sleep of depressed subjects-a polygraphic study. Psychopharmacology (Berl) 95 Suppl (1988) S37-S43
77. Ware J.C., and Pittard J.T. Increased deep sleep after trazodone use: a double-blind placebo-controlled study in healthy young adults. J Clin Psychiatry 51 Suppl (1990) 18-22
78. Montgomery I., Oswald I., Morgan K., et al. Trazodone enhances sleep in subjective quality but not in objective duration. Br J Clin Pharmacol 16 (1983) 139-144
79. Wolf P., Roder-Wanner U.U., and Brede M. Influence of therapeutic phenobarbital and phenytoin medication on the polygraphic sleep of patients with epilepsy. Epilepsia 25 (1984) 467-475
80. Malow B.A., Bowes R.J., and Lix X. Predictors of sleepiness in epilepsy patients. Sleep 20 (1997) 1105-1110
81. Brazil C.W. Effects of antiepileptic drugs on sleep structure: are all drugs equal?. CNS Drugs 17 (2003) 719-728
82. Sammaritano M., and Sherwin A. Effect of anticonvulsants on sleep. Neurology 54 (2000) S16-S24
83. Foldvary-Schaefer N., DeLeon S.I., Karafa M., et al. Gabapentin increases slow-wave sleep in normal adults. Epilepsia 43 (2002) 1493-1497
84. Cammarano W.B., Pittet J.F., Weitz S., et al. Acute withdrawal syndrome related to the administration of analgesic and sedative medications in adult intensive care unit patients. Crit Care Med 26 4 (1998) 676-684
85. Yules R.B., Lippman M.E., and Freedman D.X. Alcohol administration prior to sleep: the effect of EEG sleep stages. Arch Gen Psychiatry 16 (1967) 94-97
86. Lobo L.L., and Tufik S. Effects of alcohol on sleep parameters of sleep-deprived healthy volunteers. Sleep 20 (1997) 52-59
87. Madsen B.W., and Rossi L. Sleep and Michael-Menten elimination of ethanol. Clin Pharmacol Ther 27 (1980) 114-119
88. Kotorii T., Nakazawa Y., and Yokoyama T. Terminal sleep following delirium tremens in chronic alcoholics: polysomnographic and behavioral study. Drug Alcohol Depend 10 (1982) 125-134
89. Wetter D.W., and Young T.B. The relation between cigarette smoking and sleep disturbance. Prev Med 23 (1994) 328-334
90. Davila D.G., Hurt R.D., Offord K.P., et al. Acute effects of transdermal nicotine on sleep architecture, snoring, and sleep-disordered breathing in nonsmokers. Am J Respir Crit Care Med 150 (1994) 469-474
91. Wolter T.D., Hauri P.J., Schroeder W.J., et al. Effects of 24-hour nicotine replacement on sleep and daytime activity during smoking cessation. Prev Med 25 (1996) 601-610
92. Hughes J.R., Higgins S.T., and Bickel W.K. Nicotine withdrawal versus other drug withdrawal syndromes: similarities and dissimilarities. Addiction 89 (1994) 1461-1470
93. Lee A.H., and Afessa B. The association of nicotine replacement therapy with mortality in a medical intensive care unit. Crit Care Med 35 6 (2007) 1517-1521
94. Kripke D.F., Ancoli-Israel S., Klauber M.R., et al. Prevalence of sleep-disordered breathing in ages 40-64 years: a population-based survey. Sleep 20 (1997) 65-76
95. Young T., Palta M., Dempsey J., et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328 (1993) 1230-1235
96. Allen R.P., and Earley C.J. Restless legs syndrome: a review of clinical and pathophysiologic features. J Clin Neurophysiol 18 (2001) 128-147
97. Smith S.S., Dingwall K., Jorgenson G., et al. Associations between the use of common medications and sleep architecture in patients with untreated obstructive sleep apnea. J Clin Sleep Med 2 2 (2006) 156-162
98. Collop N.A. Medroxyprogesterone acetate and ethanol-induced exacerbation of obstructive sleep apnea. Chest 106 (1994) 792-799
99. Scrima L., Broudy M., Nay K.N., et al. Increased severity of obstructive sleep apnea after bedtime alcohol ingestion: diagnostic potential and proposed mechanism of action. Sleep 5 (1982) 318-328
100. Taasan V.C., Block A.J., Boysen P.G., et al. Alcohol increases sleep apnea and oxygen desaturation in asymptomatic men. Am J Med 71 (1981) 240-245
101. Dolly F.R., and Block A.J. Effect of flurazepam on sleep-disordered breathing and nocturnal desaturation in asymptomatic subjects. Am J Med 73 (1982) 239-243
102. Mendelson W.B., Garnett D., and Gillin J.C. Flurazepam-induced sleep apnea syndrome in a patient with insomnia and mild sleep-related respiratory changes. J Nerv Ment Dis 160 (1981) 261-264
103. Cately D.M., Thornton C., Jordan C., et al. Pronounced episodic oxygen desaturation in the postoperative period: its association with ventilatory pattern and analgesic regimen. Anesthesiology 63 (1985) 20-28
104. Robinson R.W., Zwillich C.W., Bixler E.O., et al. Effects of oral narcotics on sleep-disordered breathing in healthy adults. Chest 91 (1987) 197-203
105. Salin-Pascual R.J., Galicia-Polo L., and Drucker-Colin R. Sleep changes after 4 consecutive days of venlafaxine administration in normal volunteers. J Clin Psychiatry 58 (1997) 348-350
106. Aldrich M.S., and Shipley J.E. Alcohol use and periodic limb movements of sleep. Alcohol Clin Exp Res 17 (1993) 192-196
107. Noaves M.A., Knobel E., Bork A.M., et al. Stressors in ICU: perception of the patient, relatives and health care team. Intensive Care Med 25 (1999) 1421-1426
108. Rotondi A.J., Lakshmipathi C., Sirio C., et al. Patients' recollections of stressful experiences while receiving prolonged mechanical ventilation in an intensive care unit. Crit Care Med 30 (2002) 746-752
109. Nelson J.E., Meier D.E., Oei E.J., et al. Self-reported symptom experience of critically ill cancer patients receiving intensive care. Crit Care Med 29 (2001) 277-282
110. Freedman N., Kotzer N., and Schwab R. Patient perception of sleep quality and etiology of sleep disruption in the intensive care unit. Am J Respir Crit Care Med 159 (1999) 1155-1162
111. Simini B. Patients' perceptions of intensive care. Lancet 354 (1999) 571-572